BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 30907518)

  • 1. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
    Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
    Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
    Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
    Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
    Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
    Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
    Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
    Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinesin 18A expression: clinical relevance to colorectal cancer progression.
    Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M
    Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
    Zhang J; Sun G; Mei X
    Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma.
    Xie T; Li X; Ye F; Lu C; Huang H; Wang F; Cao X; Zhong C
    Biochem Biophys Res Commun; 2018 Feb; 497(1):65-72. PubMed ID: 29427669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
    Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer.
    Zhang H; Shen T; Zhang Z; Li Y; Pan Z
    Med Sci Monit; 2019 Aug; 25():6418-6428. PubMed ID: 31451680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinesin Family Member 18A (KIF18A) Contributes to the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells In Vitro and In Vivo.
    Chen FT; Zhong FK
    Dis Markers; 2019; 2019():6383685. PubMed ID: 31772692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of
    Feng Z; Zhang J; Zheng Y; Wang Q; Min X; Tian T
    Per Med; 2021 Mar; 18(2):115-127. PubMed ID: 33576264
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma.
    Song Y; Chen D; Zhang X; Luo Y; Li S
    Thorac Cancer; 2019 May; 10(5):1220-1228. PubMed ID: 30993904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis.
    Yang M; Sun Y; Sun J; Wang Z; Zhou Y; Yao G; Gu Y; Zhang H; Zhao H
    Cancer Med; 2018 Apr; 7(4):1081-1092. PubMed ID: 29522283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
    Yu L; Qiao R; Xu J; Han B; Zhong R
    Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
    Zhang JT; Lin YC; Xiao BF; Yu BT
    Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.